RECRUITING Not applicable ClinicalTrials.gov

Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents

Sponsor: Boston Medical Center • ClinicalTrials.gov ID: NCT06732596

Registry updated: 2026-09-30

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Description

This study aims to improve retention in buprenorphine treatment, a medication used for opioid use disorder, through the use of a smartphone-delivered recovery support intervention. The intervention involves an Embodied Conversational Agent (ECA), a virtual, animated computer agent designed to simulate natural face-to-face conversations. ECAs have been shown to help individuals manage their healthcare in other settings, and this study seeks to evaluate their potential in supporting patients on medication for opioid use disorder (MOUD).

Interventions

Embodied conversational agent (ECA) (Other)
The app with the ECA will be provided.
Technical support (Other)
Technical support will include assistance downloading and setting up the app on the participant's phone, walking them through a brief demonstration, and answering any questions the participant has about how to use the app.
Additional ECA messages (Other)
Weekly text messages will be provided reminding participants to use the app on behalf of OBAT clinical staff.
Additional incentives (Other)
Additional incentives will be provided after logging into the app for 20 days followed by monthly lotteries for those who log in 15 days per month

Eligibility criteria

Inclusion Criteria: * Diagnosis of Opioid Use Disorder (OUD) * Within 30 days of intake at recruitment site (BMC OBAT) * Possession of a smartphone that has minimum requirements * English-speaking and reading * Willing to release electronic health record (EHR) data * Able to provide at least two alternate contacts who usually know how to get in touch with them * Currently prescribed buprenorphine from an outpatient clinic Exclusion Criteria: * Incarceration anticipated within 12 months of enrollment * Inability to comprehend the study protocol, defined as failing three times to answer correctly a set of questions during the consent process * Inability to use the ECA app (i.e., due to markedly limited visual or auditory acuity or motor function required to interact with the ECA)

Conditions

Opioid Use Disorder

Locations

Office-Based Addiction Treatment (OBAT) Clinic, BMC — Boston, Massachusetts, United States

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record

Accelerate Your Clinical Trial Recruitment